StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3081% below fair value
$6.10−0.51 (-7.72%)

Close on Nov 18, 2026Market cap $24.59MP/E –Yield –

Rockwell Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Rockwell Medical's operating income for the twelve months ending Jun 30, 2026 was -$4.52M. For fiscal 2025 it was -$4.69M, down 871.5% from the year before. The highest annual figure on record is $608.00K in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.69M-871.5%
FY2024Dec 31, 2024$608.00K–
FY2023Dec 31, 2023-$6.67M–
FY2022Dec 31, 2022-$16.78M–
FY2021Dec 31, 2021-$30.34M–
FY2020Dec 31, 2020-$28.42M–
FY2019Dec 31, 2019-$34.53M–
FY2018Dec 31, 2018-$32.44M–
FY2017Dec 31, 2017-$25.92M–
FY2016Dec 31, 2016-$20.21M–
FY2015Dec 31, 2015-$15.10M–
FY2014Dec 31, 2014-$17.56M–
FY2013Dec 31, 2013-$47.06M–
FY2012Dec 31, 2012-$54.26M–
FY2011Dec 31, 2011-$21.68M–
FY2010Dec 31, 2010-$2.87M–
FY2009Dec 31, 2009-$5.48M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.06M–
Q1 FY2026Mar 31, 2026-$1.48M–
Q4 FY2025Dec 31, 2025-$398.00K–
Q3 FY2025Sep 30, 2025-$1.58M-181.8%
Q2 FY2025Jun 30, 2025-$1.35M-361.9%
Q1 FY2025Mar 31, 2025-$1.36M–
Q4 FY2024Dec 31, 2024-$519.00K–
Q3 FY2024Sep 30, 2024$1.94M–
Q2 FY2024Jun 30, 2024$515.00K–
Q1 FY2024Mar 31, 2024-$1.32M–
Q4 FY2023Dec 31, 2023-$547.00K–
Q3 FY2023Sep 30, 2023-$1.74M–
Q2 FY2023Jun 30, 2023-$2.96M–
Q1 FY2023Mar 31, 2023-$1.43M–
Q4 FY2022Dec 31, 2022-$1.97M–
Q3 FY2022Sep 30, 2022-$3.71M–
Q2 FY2022Jun 30, 2022-$4.48M–
Q1 FY2022Mar 31, 2022-$6.63M–
Q4 FY2021Dec 31, 2021-$8.36M–
Q3 FY2021Sep 30, 2021-$6.97M–
Q2 FY2021Jun 30, 2021-$7.82M–
Q1 FY2021Mar 31, 2021-$7.18M–
Q4 FY2020Dec 31, 2020-$8.07M–
Q3 FY2020Sep 30, 2020-$6.69M–
Q2 FY2020Jun 30, 2020-$5.60M–
Q1 FY2020Mar 31, 2020-$8.06M–
Q4 FY2019Dec 31, 2019-$7.40M–
Q3 FY2019Sep 30, 2019-$7.94M–
Q2 FY2019Jun 30, 2019-$10.37M–
Q1 FY2019Mar 31, 2019-$8.81M–
Q4 FY2018Dec 31, 2018-$9.42M–
Q3 FY2018Sep 30, 2018-$5.00M–
Q2 FY2018Jun 30, 2018-$12.30M–
Q1 FY2018Mar 31, 2018-$5.72M–
Q4 FY2017Dec 31, 2017-$9.22M–
Q3 FY2017Sep 30, 2017-$5.03M–
Q2 FY2017Jun 30, 2017-$6.72M–
Q1 FY2017Mar 31, 2017-$4.96M–
Q4 FY2016Dec 31, 2016-$5.26M–
Q3 FY2016Sep 30, 2016-$4.75M–

More Rockwell Medical figures

See a number that looks wrong?